ACS Medicinal Chemistry Letters · 2012 · 57 citations · 22 references
Life SciencesMedicinal ChemistryPharmacologyMolecular ImagingNeurodegenerationPrion DiseasesAlzheimer DiseaseNeurodegenerative DiseasesNeurodegenerative DisordersPrion Protein MisfoldingPrion ReplicationProtein Aggregation DisordersAmyloid Plaque FormationBlood-brain Barrier PermeabilityFluorescent Amyloid StainingFluorescent DyesFluorescent LabelingFluorescent LabelsPrion PathogenesisSelectivity
(E)-6-Methyl-4'-amino-2-styrylquinoline (3) is a small molecule with the proper features to potentially diagnose, deliver therapy and monitor response to therapy in protein misfolding diseases. These features include compound fluorescent emission in the NIR region and its ability to interact with both Aβ and prion fibrils, staining them with high selectivity. Styrylquinoline 3 also inhibits Aβ self-aggregation in vitro and prion replication in the submicromolar range in a cellular context. Furthermore, it is not toxic and is able to cross the blood brain barrier in vitro (PAMPA test).
22
Fluorescent probes for sensing and imaging
Tasuku Ueno, Tetsuo Nagano · Nature Methods · 2011 · 629 citations
Cell biology. A unifying role for prions in neurodegenerative diseases.
Stanley B. Prusiner · PubMed · 2012 · 492 citations · Full text